Treatment Information

Back

Prostate Cancer treatment details. Chemotherapy, Hormone, Surgery.

Technische Universität München, Munich, Germany.

Survival: monthsCountry:Germany
Toxiciy Grade:4City/State/Province:Munich
Treatments:Chemotherapy, Hormone, SurgeryHospital:Technische Universität München
Drugs:Journal:Link
Date:Mar 2014

Description:

Patients:
This phase 2 study involved 30 male, locally advanced and high-risk prostate cancer patients with a median age of 68 years.

Treatment:
Patients received chemotherapy with docetaxel, androgen blockade (hormone therapy) with trimestral buserelin and bicalutamide, and surgery.

Toxicities:
The most severe toxicities were grade 4 neutropenia and leucopenia. Grade 2 fatigue and alopecia were also reported.

Results:
The median overall survival was 85.3 months.

Support:
This study was supported by Sanofi-Aventis.

Correspondence: Dr. Mark Thalgott; email: mark.thalgott@lrz.tum.de



Back